Stocksigma LogoStocksigma Logo

Ipca Labs Q1FY27: Revenue Guidance Raised, Margins Improve on Strong Growth

Ipca Labs reported strong Q1FY27 results, with consolidated revenue up 21% YoY to INR 2,788 crores. Consolidated EBITDA margin improved significantly to

Ipca Labs Q1FY27: Revenue Guidance Raised, Margins Improve on Strong Growth

Ipca Laboratories Ltd 路 Transcript 路 17 Aug 2026, 5:29 pm

Ipca Labs Q1FY27: Revenue Guidance Raised, Margins Improve on Strong Growth Ipca Labs reported strong Q1FY27 results, with consolidated revenue up 21% YoY to INR 2,788 crores. Consolidated EBITDA margin improved significantly to 22.88% from 18.39% in Q1FY26, driven by operating leverage. Domestic formulations grew 13%, exports 34%, and APIs 30%. Citing strong performance, management raised full-year FY27 revenue growth guidance to 14-16% from 12-13% previously. FY27 consolidated EBITDA margin guidance was also revised upwards to ~23% from 22%. Capex is guided at INR 700-800 crores for the year.

Original exchange filing (PDF)

More announcements from Ipca Laboratories Ltd

All Ipca Laboratories Ltd announcements